featured
Do GLP‐1 Receptor Agonists and SGLT2 Inhibitors Lower CV Events in Black Patients With Type 2 Diabetes?
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism